XML 39 R31.htm IDEA: XBRL DOCUMENT

Warrants (Tables)

12 Months Ended

Dec. 31, 2014

Warrants Tables

Warrant activity and summary

The following summarizes activity with respect to MicroVision common stock warrants during the two years ended December 31, 2014:

						Warrants to			Weighted
						purchase			average
						common			exercise
						shares			price
Outstanding at December 31, 2012						5,131,000		$	7.28
Granted:
Exercise price less than intrinsic value						2,216,000			2.71
Exercise price greater than intrinsic value						1,855,000			2.44
Exercised						(358,000)			1.77
Canceled/expired						(753,000)			28.80
Outstanding at December 31, 2013						8,091,000		$	3.07
Granted:
Exercise price less than intrinsic value						-			-
Exercise price greater than intrinsic value						2,148,000			2.47
Exercised						(3,713,000)			2.67
Canceled/expired						-			-
Outstanding at December 31, 2014						6,526,000		$	3.08

Exercisable at December 31, 2014						6,526,000		$	3.08

The following table summarizes information about our common stock warrants outstanding and exercisable at December 31, 2014:

			Warrants outstanding									Warrants exercisable
						Weighted
			Number			average			Weighted			Number			Weighted
			outstanding at			remaining			average			exercisable at			average
			December 31,			contractual			exercise			December 31,			exercise
Range of exercise prices			2014			life (years)			price			2014			price

$2.13			1,000,000			0.39		$	2.13			1,000,000		$	2.13
$2.24			2,100,000			2.47			2.24			2,100,000			2.24
$2.47			2,148,000			4.21			2.47			2,148,000			2.47
$6.24			1,278,000			1.88			6.24			1,278,000			6.24
$2.13-$6.24			6,526,000									6,526,000

Tabular disclosure of components of a stock option or other award plan under which equity-based compensation is awarded to employees, typically comprised of the amount of unearned compensation (deferred compensation cost), compensation expense, and changes in the quantity and fair value of the shares (or other type of equity) granted, exercised, forfeited, and issued and outstanding pertaining to that plan. Disclosure may also include nature and general terms of such arrangements that existed during the period and potential effects of those arrangements on shareholders, effect of compensation cost arising from equity-based payment arrangements on the income statement, method of estimating the fair value of the goods or services received, or the fair value of the equity instruments granted, during the period, cash flow effects resulting from equity-based payment arrangements and, for registrants that accelerate vesting of out of the money share options, reasons for the decision to accelerate.

+ References+ Details